Surfactant Mildness Index: Zein Test, TEWL Impact & Skin Barrier Safety Data

Overview #

pH is not just a formulation parameter in cleanser development — it is the primary determinant of whether your surfactant system strips the barrier or respects it. We use the Zein solubilization test and transepidermal water loss (TEWL) measurement as our two core screening tools before any cleanser formula moves to stability. Not because they’re the only tools, but because they give us the fastest signal on mildness before we commit to a full clinical run. Most brand partners come to us asking about foam quality and fragrance. The first question we ask is: what’s your target skin type, and what TEWL delta are you willing to accept?

Surfactant Mildness: What the Zein Test Actually Tells You #

The Zein test measures protein solubilization — specifically, how much zein protein (a corn-derived prolamin used as a skin model) a surfactant system dissolves at a fixed concentration and contact time. In our lab, we run it at 0.1% active surfactant concentration, 40°C, 1-hour contact, and read absorbance at 278 nm. A score above 1.0 OD units is a red flag. Sodium lauryl sulfate (SLS) at 0.1% typically reads 1.8–2.2 OD in our system. A well-formulated amino acid surfactant blend comes in at 0.3–0.5 OD. That gap is real and it matters.

What the Zein test doesn’t tell you is the full story. It’s a single-protein model at a fixed pH, and it doesn’t capture the synergistic mildness effects you get from co-surfactant blending. We’ve had formulas score well on Zein but still show elevated TEWL in patch testing — usually because the rinse profile was poor or the formula pH was drifting during the test window. So we treat Zein as a screening gate, not a final verdict.

The mildness hierarchy we work from in practice: sodium cocoyl glutamate and sodium lauroyl sarcosinate consistently outperform alkyl sulfates. Amphoteric co-surfactants like cocamidopropyl betaine (CAPB) at 20–30% of total surfactant load reliably pull Zein scores down by 0.4–0.7 OD units in our blends. That’s not a small effect.

TEWL Impact and Barrier Safety Data #

TEWL is the clinical endpoint that actually connects formulation decisions to skin health outcomes. In our internal patch studies, we use a 24-hour occlusive patch protocol followed by 1-hour open exposure, then measure with a Tewameter TM 300. Baseline TEWL for healthy volar forearm skin in our test population runs 6–10 g/m²/h. A cleanser that pushes post-wash TEWL above 18 g/m²/h is, in our view, not suitable for sensitive skin positioning.

The clinical reference we anchor to: a double-blind, randomized controlled study (n=42, 8 weeks, twice-daily washing) comparing an SLS-based cleanser against a sodium cocoyl isethionate (SCI) / CAPB blend. The SLS group showed a mean TEWL increase of 34% from baseline by week 4, with no recovery to baseline by week 8. The SCI/CAPB group showed a mean TEWL increase of 9% at week 4, returning to within 3% of baseline by week 6. Stratum corneum hydration (measured by corneometry) followed the same pattern. That 34% vs. 9% delta is the number we show brand partners when they push back on switching from SLS.

For brands targeting eczema-prone or compromised barrier skin, we set an internal threshold: post-wash TEWL delta must stay below 12% from baseline in our patch protocol before we’ll recommend the formula for that positioning. Most amino acid surfactant systems hit this. Most sulfate-dominant systems don’t. It’s not complicated — but it does require the right raw material choices from the start.

Regulatory context matters here too. The EU Cosmetics Regulation 1223/2009 doesn’t set explicit TEWL thresholds, but it does require that safety assessments address skin sensitization and barrier disruption potential. If you’re selling into the EU and making a “gentle” or “sensitive skin” claim, you need data. TEWL data is the most defensible format we’ve seen accepted by EU safety assessors.

See also our internal documentation on barrier-repair and sensitive skin formulation approaches for how we extend these principles beyond cleansers.

Key Degradation Conditions and Stability Thresholds #

Cleanser stability is underestimated. Brands focus on active ingredient stability — retinol, vitamin C — but surfactant systems degrade too, and the failure modes are different.

The primary degradation risks we track:

Hydrolysis of ester-linked surfactants. Sodium cocoyl isethionate and similar ester-linked materials are pH-sensitive. Below pH 4.5 or above pH 9.0, hydrolysis accelerates measurably. In our accelerated stability protocol (40°C/75% RH, 12 weeks), SCI-based formulas held at pH 5.5–6.5 show less than 5% viscosity drift. The same formula adjusted to pH 4.0 shows 18–22% viscosity drop by week 8. That’s a failed batch.

Microbial challenge in low-surfactant systems. Micellar waters and low-foam cleansers with total surfactant active below 8% are harder to preserve than you’d expect. The surfactant itself contributes antimicrobial activity. Drop below that threshold and your preservative system has to work harder. We’ve had a micellar formula pass challenge testing at lab scale (500g batch) and then show gram-negative contamination at week 10 of PCT on the 200kg production batch. The difference was water activity and mixing shear — the production batch had slightly higher free water due to incomplete homogenization. We now require inline conductivity checks at production scale to catch this.

Fragrance-surfactant incompatibility. This is where most projects go sideways. Fragrance loads above 0.5% in amino acid surfactant systems frequently cause viscosity instability and phase separation, especially with citrus-heavy fragrance profiles. We’ve seen emulsion-type cleansing balms collapse entirely when fragrance load exceeded 0.8%. The fix is usually fragrance encapsulation or switching to a more compatible fragrance base — but encapsulation adds cost, roughly 2.5–3× the raw material price of the fragrance itself.

Temperature cycling. Freeze-thaw cycling (–5°C to +40°C, 3 cycles) is our standard screen for cleansing balms and oil-based cleansers. Wax-based systems with melting points below 38°C are at risk of phase separation on the warm end of that cycle. We set a minimum wax melting point of 42°C for any balm formula targeting markets with warm logistics chains (Southeast Asia, Middle East).

For ISO challenge testing methodology, refer to ISO Standards — specifically ISO 11930 for preservation efficacy evaluation of cosmetic products.

Incompatible Combinations We’ve Learned the Hard Way #

Anionic and cationic surfactants in the same phase. Short answer: don’t try to combine these two in the same phase. The ion-pair complex they form is insoluble, and it will crash out of solution. We see this occasionally when brand partners want to add a conditioning agent (typically a quaternary ammonium compound) to an anionic surfactant base without understanding the chemistry. The fix is sequential addition with a pH adjustment step, or reformulating with an amphoteric system as the bridge. It’s solvable, but it adds development time.

Chelating agents and certain preservative systems. EDTA at 0.1% is standard in our cleansers for metal ion control and preservative boosting. But in formulas using phenoxyethanol/ethylhexylglycerin blends, EDTA can interact with the ethylhexylglycerin at low pH, reducing effective preservative activity. We’ve seen this in formulas targeting pH 4.8–5.2 with high mineral water content. The supplier data and our stability results don’t always agree on this one — we’ve had batches where the interaction was negligible and others where it clearly wasn’t. Our current approach is to run a full challenge test whenever we’re combining these at pH below 5.5.

High-load botanical extracts in surfactant systems. Tannin-rich extracts — green tea, pomegranate, witch hazel — interact with cationic and amphoteric surfactants to form haze or precipitate. We’ve rejected more than a few briefs that asked for 3–5% green tea extract in a CAPB-based foam cleanser. At 1% or below, it’s usually manageable. Above that, you’re fighting the chemistry.

For brands developing acne-focused cleansers with salicylic acid, the pH constraint is tight. Salicylic acid requires pH ≤3.8 for meaningful free acid activity, but most mild surfactant systems are unstable below pH 4.5. We almost always push back on this brief. The compromise is usually a two-step system or a leave-on toner rather than trying to force both requirements into a single rinse-off formula. See our notes on acid exfoliation technology for how we handle this in leave-on formats.

Packaging Recommendations #

Packaging is not an afterthought in cleanser development. It directly affects stability outcomes.

Airless pump dispensers are the gold standard for preservative-sensitive formulas — particularly low-surfactant micellar systems and amino acid cleansers with minimal preservative load. The problem is cost. Airless pump adds $0.40–$0.80 per unit at MOQ 1,000 units. Most indie brands can’t absorb that, especially on a cleanser SKU where retail price pressure is real. So we end up recommending a conventional pump with a well-validated preservative system instead. It’s not a perfect solution.

For cleansing balms in jar packaging: we require a minimum 2mm wall thickness on the jar body for thermal stability, and we specify UV-blocking pigment in the cap for any formula containing antioxidant actives. Clear jars look beautiful on shelf. They also accelerate oxidative degradation of any phenolic botanical extract in the formula.

Tube packaging for cream cleansers — standard laminate tubes are fine for most formulas at pH 5.0–7.0. Below pH 4.5, we specify aluminum barrier laminate to prevent acid migration into the adhesive layer. We’ve had one project where a citric acid-heavy brightening cleanser at pH 4.2 caused delamination of a standard PE tube by month 3 of stability. The brand had already printed 50,000 units. That was an expensive lesson.

The FDA Cosmetics Guidelines and NMPA Cosmetic Regulation both address packaging compatibility requirements, though the specifics differ. For products targeting both US and China markets, we recommend running packaging compatibility testing under both frameworks from the start — retrofitting is painful.

Formulation Notes for Brand Partners #

What market? What are you expecting on-pack? Those are the first two questions we ask every brand partner who comes to us with a cleanser brief.

If you’re targeting EU sensitive skin with a “dermatologist-tested, barrier-safe” claim, we’re going to build your formula around amino acid surfactants at pH 5.5–6.0, run Zein screening on every candidate blend, and require TEWL patch data before we sign off on the claim. That process takes 10–14 weeks from brief to stability-confirmed formula. Budget accordingly.

If you’re targeting the US mass market with a foaming cleanser and a clean beauty positioning, the conversation is different. Clean beauty consumers are increasingly skeptical of sulfates — even sodium cocoyl sulfate, which has a genuinely better mildness profile than SLS. We’ve seen brands lose retail listings because the INCI listed any sulfate, regardless of the actual mildness data. That’s a market reality, not a chemistry reality. We’ll formulate around it, but we want you to understand the trade-off: amino acid surfactant systems cost 30–50% more in raw materials than sulfate-based systems at equivalent active concentration.

For China NMPA registration, rinse-off cleansers are general cosmetics but still require full safety dossiers. If you’re adding any functional actives — salicylic acid, niacinamide above 2%, certain botanical extracts — the registration pathway changes. Tell us upfront. It affects formulation decisions from day one.

Honestly, the brands that have the smoothest development cycles are the ones who come in with a clear skin type target, a realistic price point, and flexibility on fragrance. The ones who struggle are usually trying to hit a $4.00 FOB with an amino acid surfactant system and 1.5% fragrance load. The math doesn’t work.

Frequently Asked Questions #

Q: We want to call it “sulfate-free and gentle” on pack — does that automatically mean it’s mild?

Not automatically. Sulfate-free just means no alkyl sulfates — you can still have an aggressive surfactant system without them. We run Zein and TEWL screening on every formula regardless of the surfactant class. A sulfate-free formula with a Zein score above 1.0 OD is not a mild formula, and we won’t sign off on that claim.

Q: What pH should our foaming cleanser be at?

For a general-use foaming cleanser, we target pH 5.5–6.5. That range balances mildness, preservative efficacy, and surfactant stability. If you’re going below pH 5.0 for an active ingredient reason, we need to know upfront — it changes the surfactant selection and the preservative system.

Q: How long does cleanser stability testing take before we can launch?

Our standard protocol is 12 weeks at 40°C/75% RH plus 3 freeze-thaw cycles. Real-time ambient (25°C/60% RH) runs in parallel for 6 months minimum before we recommend commercial launch. For EU or NMPA registration, you’ll need the full 6-month real-time data anyway. Plan for 6–8 months from formula lock to stability-cleared launch.

Q: Can we add 2% niacinamide to a low-pH cleanser for brightening?

Niacinamide and low pH are a known compatibility issue — below pH 4.0, niacinamide hydrolyzes to nicotinic acid, which causes flushing. In a rinse-off cleanser at pH 5.0–5.5, the contact time is short enough that hydrolysis is minimal, and 2% niacinamide is workable. Below pH 4.5, we’d steer you toward a different brightening active for the cleanser step and keep the niacinamide in a leave-on format.

Q: We’ve seen “microbiome-friendly” cleansers — what does that actually require in formulation?

It means keeping the formula pH close to skin’s natural range (4.5–5.5), avoiding high-dose preservatives that disrupt commensal bacteria, and ideally using surfactants with low antimicrobial activity against Staphylococcus epidermidis. We can formulate to this brief, but “microbiome-friendly” is not a regulated claim — you’ll need your own in-vitro or clinical data to support it. The SCCS Scientific Opinion framework is the most rigorous reference point for substantiating skin microbiome claims in the EU market.

Have a product concept in mind? Contact our formulation team to request a complimentary brief review.